( MENAFN - GlobeNewsWire - Nasdaq) Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets's offering. With thousands of potential therapies on the market, cell and gene therapy promises future potential for pharmaceutical developers and those serving them. The new twice-monthly publication dedicated to cell and gene therapy, Cell and Gene Therapy Business Outlook will offer the following: Cell and Gene Therapy Business Outlook is created by market researchers and editors focused on business opportunity.
Each issue will track the market size and potential for a key market segment. Each issue of Cell and Gene Therapy Business Outlook will keep track of mergers, investments, licensing, technology transfers and partnerships in the industry. Each issue of Cell and Gene Therapy Business Outlook contains an updated CGT Recent Deals Table with information on these important events.
With a focus on what the recent news of the day means for business, the curated news and news analysis means that you and your organization can be confident you won't miss an important development in cell and gene therapy. For more information about this report visit About ResearchAndMarkets ResearchAndMarkets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest.
